Lactose (India) Ltd | 138 Cr. | 97.8 | 247/84.3 | 19.9 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.03 Cr. | 2.63 | 4.33/2.61 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 43.1 Cr. | 58.1 | 94.9/44.5 | 14.6 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 27.6 Cr. | 18.8 | 29.0/13.1 | 28.1 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 70.8 Cr. | 94.0 | 155/79.0 | 11.4 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 40,014 Cr. | 1,417 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Gennex Laboratories Ltd | 297 Cr. | 13.0 | 29.0/11.2 | 15.9 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.53 Cr. | 13.5 | 27.1/9.25 | 131 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 318 Cr. | 674 | 956/635 | 16.9 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 100 Cr. | 23.0 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 784 Cr. | 266 | 449/145 | 22.2 | 98.6 | 0.47 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.45 Cr. | 26.0 | 36.5/22.8 | 109 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 8.69 Cr. | 3.49 | 12.3/2.11 | 96.6 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 376 Cr. | 387 | 477/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 6,327 Cr. | 1,454 | 1,584/991 | 70.2 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 131 Cr. | 1.41 | 2.72/1.03 | 27.8 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 55.4 Cr. | 23.0 | 23.8/6.40 | 66.7 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 12.0 Cr. | 11.8 | 24.6/10.0 | 51.9 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 247 Cr. | 693 | 999/368 | 9.10 | 570 | 0.29 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 30.9 Cr. | 30.9 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 25.7 Cr. | 56.3 | 88.7/36.0 | 52.5 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 9.02 Cr. | 3.61 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.7 Cr. | 124 | 154/55.1 | 46.7 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 12.9 Cr. | 23.6 | 28.9/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 42.2 Cr. | 56.0 | 120/50.0 | 26.7 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 4.94 Cr. | 16.5 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,347 Cr. | 769 | 969/347 | 56.8 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 97.7 Cr. | 22.6 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.67 Cr. | 19.0 | 46.0/17.4 | 121 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 156 Cr. | 270 | 418/245 | 16.0 | 110 | 1.67 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 24.6 Cr. | 41.8 | 62.6/14.8 | 70.4 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 71,701 Cr. | 1,224 | 1,593/994 | 20.2 | 527 | 0.37 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 160 Cr. | 257 | 298/156 | 46.0 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 871 Cr. | 174 | 258/148 | 17.3 | 60.5 | 1.44 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 35.2 Cr. | 27.0 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,610 Cr. | 1,173 | 1,322/504 | 60.6 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.55 Cr. | 0.84 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 284 Cr. | 37.0 | 77.7/34.1 | 20.0 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 7.95 Cr. | 13.6 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 80.1 Cr. | 3.40 | 6.25/2.82 | 121 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 64,626 Cr. | 30,390 | 31,900/25,260 | 48.4 | 1,657 | 1.35 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 7,082 Cr. | 781 | 837/496 | 26.0 | 220 | 0.38 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 152 Cr. | 54.2 | 75.8/31.3 | 26.6 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,693 Cr. | 941 | 1,078/440 | | 57.7 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 20,732 Cr. | 1,277 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 883 Cr. | 268 | 325/131 | 47.6 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 421 Cr. | 315 | 428/270 | 15.1 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,019 Cr. | 573 | 950/501 | 47.5 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,667 Cr. | 1,175 | 1,923/991 | 24.3 | 735 | 0.85 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,09,506 Cr. | 3,236 | 3,591/2,570 | 58.8 | 222 | 0.87 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,210 Cr. | 132 | 317/115 | 26.2 | 44.8 | 0.38 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,551 Cr. | 16.5 | 27.9/11.0 | 40.7 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,557 Cr. | 1,082 | 1,360/597 | 98.8 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 3,743 Cr. | 171 | 175/83.0 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,07,875 Cr. | 1,700 | 1,960/1,377 | 34.6 | 288 | 0.79 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,989 Cr. | 550 | 886/367 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,250 Cr. | 254 | 398/175 | 35.3 | 70.6 | 0.16 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 437 Cr. | 1,453 | 1,750/642 | 20.8 | 621 | 0.10 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,542 Cr. | 669 | 960/418 | 77.3 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 4,205 Cr. | 168 | 241/91.8 | 279 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,653 Cr. | 5,930 | 7,600/4,146 | 30.9 | 374 | 1.97 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,552 Cr. | 2,148 | 2,977/1,381 | 30.0 | 321 | 0.74 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 8,458 Cr. | 5,082 | 5,850/4,641 | 34.5 | 368 | 1.57 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 233 Cr. | 66.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,779 Cr. | 4,324 | 6,453/3,701 | 32.1 | 820 | 0.81 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 125 Cr. | 101 | 348/81.0 | 9.33 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 3,294 Cr. | 539 | 582/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,026 Cr. | 795 | 1,998/670 | 36.5 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 16,172 Cr. | 12,587 | 18,100/5,540 | 67.4 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 508 Cr. | 22.6 | 56.5/20.0 | 29.9 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,771 Cr. | 825 | 1,639/660 | 7.93 | 399 | 1.15 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,315 Cr. | 60.4 | 101/41.7 | 28.1 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 10,754 Cr. | 237 | 359/130 | 29.2 | 50.3 | 0.25 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 125 Cr. | 78.7 | 145/70.1 | 12.1 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 393 Cr. | 111 | 177/90.2 | 95.7 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 94,211 Cr. | 2,064 | 2,403/1,493 | 32.8 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,181 Cr. | 591 | 980/498 | 13.2 | 319 | 0.30 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 32,129 Cr. | 595 | 661/385 | 84.5 | 84.6 | 0.20 % | 10.4 % | 8.67 % | 2.00 |
Kwality Pharmaceuticals Ltd | 799 Cr. | 770 | 1,070/481 | 22.7 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 160 Cr. | 75.4 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 915 Cr. | 189 | 370/155 | 19.2 | 103 | 1.58 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 677 Cr. | 420 | 431/271 | 37.8 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,437 Cr. | 907 | 1,310/617 | 43.3 | 373 | 0.55 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 24,568 Cr. | 1,583 | 2,030/1,303 | 38.4 | 207 | 0.77 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,457 Cr. | 219 | 328/109 | 36.6 | 36.1 | 0.91 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 35,611 Cr. | 1,404 | 1,758/1,052 | 48.5 | 264 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,953 Cr. | 66.4 | 108/57.5 | 20.0 | 56.5 | 1.50 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 73.2 Cr. | 13.5 | 34.7/12.0 | 1.14 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 453 Cr. | 74.9 | 186/67.2 | 5.48 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,313 Cr. | 251 | 388/190 | | 118 | 0.60 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 5,032 Cr. | 408 | 465/267 | 67.5 | 97.6 | 0.29 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,507 Cr. | 1,769 | 3,379/1,243 | 54.8 | 369 | 0.34 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,728 Cr. | 372 | 504/278 | 45.5 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,600 Cr. | 478 | 725/389 | 24.2 | 141 | 0.31 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 40,014 Cr. | 1,417 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 47,247 Cr. | 2,789 | 3,148/1,921 | 51.1 | 115 | 1.15 % | 66.9 % | 49.6 % | 10.0 |
Gland Pharma Ltd | 23,605 Cr. | 1,433 | 2,221/1,200 | 21.0 | 557 | 1.40 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 7,116 Cr. | 437 | 659/359 | 25.9 | 141 | 1.14 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 19,716 Cr. | 1,445 | 1,594/816 | 59.9 | 204 | 0.51 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,00,748 Cr. | 1,207 | 1,421/1,020 | 17.8 | 402 | 0.66 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,267 Cr. | 209 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,22,737 Cr. | 1,520 | 1,702/1,310 | 23.3 | 386 | 0.86 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 15,237 Cr. | 2,004 | 2,641/1,221 | 29.6 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 394 Cr. | 135 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,249 Cr. | 119 | 186/92.2 | 14.8 | 99.7 | 0.42 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 70.9 Cr. | 43.6 | 92.0/40.4 | 118 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 39,596 Cr. | 330 | 405/270 | 41.2 | 180 | 0.15 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,841 Cr. | 1,824 | 2,215/1,048 | 44.9 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 160 Cr. | 101 | 158/76.3 | 22.1 | 43.2 | 1.19 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 172 Cr. | 74.8 | 96.0/67.8 | 36.9 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 20,476 Cr. | 8,190 | 9,211/5,311 | 122 | 272 | 0.29 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 2,056 Cr. | 710 | 863/544 | 41.7 | 103 | 0.65 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 220 Cr. | 105 | 145/69.9 | 8.76 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 61,275 Cr. | 5,126 | 6,440/4,407 | 28.3 | 961 | 0.78 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,607 Cr. | 896 | 1,304/725 | 30.8 | 264 | 1.23 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 504 Cr. | 884 | 1,754/763 | 29.3 | 688 | 1.30 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 32,412 Cr. | 2,593 | 3,486/2,022 | 35.2 | 290 | 1.39 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,233 Cr. | 289 | 571/258 | 24.7 | 127 | 1.77 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,172 Cr. | 454 | 635/312 | 26.5 | 136 | 0.22 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,037.97 Cr | 1,103.18 | | 43.48 | 184.02 | 0.33% | 16.21% | 17.09% | 6.19 |